ReviewAIDS and behavior2026
Barriers and Facilitators to Oral HIV Pre-exposure Prophylaxis Use in Australia: A Scoping Review Comparing Findings to Canada, New Zealand, and the United Kingdom.
Review in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral HIV pre-exposure prophylaxis (PrEP) is highly effective, yet various barriers limit its potential as a HIV prevention strategy. This scoping review aimed to identify and quantify determinants of oral PrEP initiation and continuation among community members, and provision by healthcare providers in Australia and comparable countries (UK, Canada, and New Zealand). Three databases were searched in January 2025 for original studies published between January 2018 and December 2024. We considered papers published in English from the four countries that contained primary research exploring determinants of PrEP initiation, continuation, and provision. Determinant codes were extracted, the number of times they appeared were counted, and were mapped to the updated Consolidated Framework for Implementation Science (CFIR 2.0). We identified 142 articles reporting 70 unique barriers (appearing 444 times in the 142 articles) and 49 unique facilitators (appearing 256 times in the 142 articles). Frequently identified PrEP initiation and continuation determinants-including cost, risk perception, stigma, and varying levels of PrEP knowledge and awareness-may substantially impact PrEP use and warrant further investigation. PrEP provision determinants highlighted opportunities for service innovation, such as through task-shifting and telehealth integration. Determinants absent from Australian literature suggest research opportunities in PrEP importation, telehealth delivery, task-shifting to other healthcare workers and peer workers, and PrEP use in the context of STI prophylaxis use. Research predominantly focused on gay, bisexual, and other men who have sex with men, indicating opportunities for more nuanced examination of diversity within this population, alongside further research with other key populations.
Indexed as
Identifiers
42323471What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.